Ruth Adams
Chief Tech/Sci/R&D Officer bij NUVALENT, INC.
Actieve functies van Ruth Adams
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NUVALENT, INC. | Chief Tech/Sci/R&D Officer | 01-11-2020 | - |
Loopbaan van Ruth Adams
Eerdere bekende functies van Ruth Adams
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Vigeo Therapeutics, Inc.
 Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - | - |
Opleiding van Ruth Adams
| The University of Southampton | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NUVALENT, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Vigeo Therapeutics, Inc.
Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Ruth Adams
- Ervaring
